Topic Description :
• Understanding current indications for LAAO.
• Unusual and nonclassical indications.
• Variants of antithrombotic therapy following LAAO.
Prof. Michael Glikson
MD, FESC, FACC
Director of the Jesselson Integrated Heart Center, in charge of both Cardiology and Cardiac Surgery Departments, Shaare Zedek Medical Center
Shaare Zedek Medical Center – Jerusalem, Israel
About the Speaker
Prof. Glikson graduated cardiology training at Sheba Medical Center, Israel and electrophysiology and pacing fellowship at the Mayo Clinic. He headed the Davidai Arrhythmia Center for many years till 2017 when he was appointed the head of Jesselson Integrated Heart Center at Shaare Zedek Medical Center in Jerusalem. He received full professorship in cardiology at Tel Aviv University in 2012, and an adjunct professorship of medicine at the Mayo Clinic College of Medicine and Science.
Prof Glikson’s main research interest is in cardiac pacing, defibrillation and CRT with more than 180 publications in the field. His list of publications includes 200 peer reviewed scientific research and review articles as well as 13 book chapters. He was an invited speaker at over 80 international meetings and abstract presenter of more than 370 abstracts. He was proctor of CRT, extraction and LAAO procedures in various international centers and serves as member on several editorial boards of EP journals (Europace, PACE, previously Heart Rhythm). Prof. Glikson was the initiator and principal investigator of several investigator–initiated research projects including Detect SVT, Rapture, and Raise CRT trials, in collaboration with Mayo Clinic researchers.
Over the years Prof. Glikson served as investigator and PI in more than 50 companies-initiated studies. He served as a proctor of device companies in several places around the globe.
Prof Glikson served as the secretary and the chair of the Israeli working group on pacing and electrophysiology. During his term as Chairman, he established several successful national registries including the Israeli ICD registry that has produced numerous studies and publications. He was elected Secretary General of the Israel Heart Society (2004-2008) and as the President of Israel Heart Society from 2015-2017.
In his tasks at the European Heart Rhythm Association, he served as the co-chair of the EHRA scientific program committee including the Europace 2015 meeting and the chair of the scientific program committee including Europace 2017 meeting. In his previous role on the scientific document committee Prof Glikson co-authored several scientific and consensus European documents and was the senior author and leader on a consensus paper regarding use of left atrial occlude in the first and second edition. He was recently elected to serve as a board member (Councilor) of the European Society of Cardiology 2018-2020.
Prof Glikson serves as the co-president of the International Dead Sea Symposium, a prestigious international meeting in electrophysiology and one of the most important international scientific meetings in Israel.